Direttore, BD Early Stage — CSL Behring
- Località
- Bern
- Contratto
- full-time
- Pubblicato
- Ieri
Panoramica
The Director, BD Early Stage leads the assessment of earl y- stage external innovation opportunities from Due Diligence Stage 2 to negotiation of a Non-Binding Offer ( NBO ) .
The role integrates evolving scientific advances, therapeutic trends and market dynamics to guide CSL's long-range BD investment decisions in early - stage opportunities.
It provides deep subject-matter leadership and enterprise-level judgement to ensure potential partnerships and acquisitions advance CSL’s portfolio impact, scientific differentiation and competitive positioning.
- The Director, BD Early Stage leads the assessment of earl y- stage external innovation opportunities from Due Diligence Stage 2 to negotiation of a Non-Binding Offer ( NBO ) .
- The role integrates evolving scientific advances, therapeutic trends and market dynamics to guide CSL's long-range BD investment decisions in early - stage opportunities.
- & Accountabilities External Innovation Evaluation Leadership:
- Lead evaluation of early-stage external assets, technologies, platforms and modalities aligned to TA Strategy from Due Diligence Stage 2 through Governance to negotiation of NBO.
- CSL’s evaluation standards and prioritization frameworks to ensure rigor, consistency and balanced risk-benefit assessment.
Responsabilità principali
- & Accountabilities External Innovation Evaluation Leadership:
- Lead evaluation of early-stage external assets, technologies, platforms and modalities aligned to TA Strategy from Due Diligence Stage 2 through Governance to negotiation of NBO.
- Integrate scientific, clinical, mechanistic, regulatory and commercial evidence into holistic assessments of attractiveness, differentiation and enterprise and TA strategic fit.
- Development of Investment-Ready Assessments:
- Deliver investment-quality inputs such as valuation assumptions, scenario modelling, unmet need assessments, deal analogues and downstream implications (e.g., biomarker requirements, specialized development pathways, manufacturing needs).
- Translate complex scientific and clinical narratives into clear, concise and decision-ready recommendations for CSL senior leaders.
- Strategic Judgement and Opportunity Prioritization:
- Provide recommendations on progressing, deferring or declining opportunities based on enterprise priorities and the TA Strategy.
Cosa offre l’azienda
- CSL’s evaluation standards and prioritization frameworks to ensure rigor, consistency and balanced risk-benefit assessment.
Processo di candidatura
- Cross-Functional Partnership and Collaboration:
- Develop and maintain key external partnerships with potential partners in close collaboration with R&D Search.
- Partner with BD Transactions to shape valuation logic, risk scenarios, deal structures and diligence readiness for advanced opportunities.
- Engage with global cross-functional partners including Commercial, Medical, Clinical Development, Regulatory, Technical Operations, Strategy, Finance to inform integrated and robust evaluation outputs.
- Governance and Decision Support:
- Prepare high-quality evaluation summaries, strategic assessments and decision papers for enterprise governance (e.g.
- PRISM, REDC) and other senior bodies as needed (e.g. PDCa, IDC)
- Ensure evaluation outputs reflect analytical depth, strategic clarity, scientific credibility and integrated cross-functional perspectives.
Azienda e contesto
- Strengthen organizational capability in scientific evaluation, market analysis, disease modelling and structured diligence within the BD function. JOB SPECIFICATIONS Education
- Bachelor’s degree in Life Sciences, Medicine, Pharmacy, Biology, Physiology or a related discipline (required) ;
- Advanced degree such as PhD, MD, PharmD, MSc, MBA, or equivalent scientific/commercial qualification ( strongly preferred) . Experience
- 5-10+ years in pharmaceutical/biotech with substantive exposure to Search & Evaluation, early ‑ stage BD, R&D strategy or new product planning
- Proven ability to assess scientific/commercial potential and influence governance decisions
- Demonstrated success evaluating external opportunities, leading negotiations and influencing cross-functional and senior-level decisions
- Experience partnering across R&D, Commercial, Finance, Regulatory, and Transactions in a global matrix
- Proven ability supporting investment cases and contribute meaningfully to diligence and strategic evaluations Competencies
- Strong scientific literacy across modalities and early development (discovery/preclinical through Phase I) High analytical capab
Dettagli ulteriori
- Responsibilities & Accountabilities External Innovation Evaluation Leadership:
- Apply CSL’s evaluation standards and prioritization frameworks to ensure rigor, consistency and balanced risk-benefit assessment.
- PRISM, REDC) and other senior bodies as needed (e.g.
- Support enterprise capital allocation and portfolio shaping discussions with clear strategic logic and evidence-driven recommendations. Team Leadership & Capability Development
- Strengthen organizational capability in scientific evaluation, market analysis, disease modelling and structured diligence within the BD function. JOB SPECIFICATIONS
- Advanced degree such as PhD, MD, PharmD, MSc, MBA, or equivalent scientific/commercial qualification ( strongly preferred) .
- Proven ability supporting investment cases and contribute meaningfully to diligence and strategic evaluations
- Strong scientific literacy across modalities and early development (discovery/preclinical through Phase I) High analytical capab
Note e contenuto originale
- Responsibilities & Accountabilities
- External Innovation Evaluation Leadership:
- Support enterprise capital allocation and portfolio shaping discussions with clear strategic logic and evidence-driven recommendations.
- Team Leadership & Capability Development
- Strengthen organizational capability in scientific evaluation, market analysis, disease modelling and structured diligence within the BD function.
- JOB SPECIFICATIONS
- Experience
- Competencies
- Strong scientific literacy across modalities and early development (discovery/preclinical through Phase I)
- High analytical capab
Domande frequenti su questo annuncio
Che stipendio offre CSL Behring per questa posizione?
CSL Behring indica CHF 57'500 - 87'000 lordi annui per questo ruolo a Bern. Questo è lo stipendio pubblicato nell'annuncio originale (o, quando il datore non specifica una cifra, una stima realistica per ruolo e settore) — il calcolatore di questo sito lo converte nel netto reale una volta applicate imposta da frontaliere e contributi sociali.
È un ruolo a tempo pieno, e che tipo di contratto offre CSL Behring?
Questo annuncio è una posizione a tempo pieno. Il tipo di contratto mostrato qui arriva direttamente dall'annuncio originale del datore di lavoro; conferma sempre orario esatto, preavviso e durata del periodo di prova con CSL Behring durante il colloquio, perché questi dettagli possono variare anche all'interno della stessa categoria contrattuale.
Serve un permesso da frontaliere per un ruolo nel canton Berna?
I residenti UE/AELS nella zona di frontiera del paese confinante con il canton Berna possono richiedere il Permesso G; il datore di lavoro svizzero lo presenta all'ufficio della migrazione di quel canton dopo la firma del contratto. Regole sulla zona di frontiera e tempi di lavorazione variano per paese confinante e canton — verifica i dettagli con l'ufficio della migrazione del canton Berna o con HR durante il colloquio.
Come mi candido a questa posizione presso CSL Behring?
Usa il pulsante "Candidati ora" in questa pagina — rimanda direttamente all'annuncio originale di CSL Behring su csl.wd1.myworkdayjobs.com, quindi la tua candidatura arriva direttamente nel sistema di gestione candidature del datore di lavoro. Frontaliere Ticino non raccoglie né inoltra candidature in proprio.
